Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

291 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis

NCT07483450

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • Peking Union Medical College Hospital Beijing, China
  • Peking University First Hospital Beijing, China
  • Beijing Hospital of Ministry of Health Beijing, China
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

NCT06292923

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Yale North Haven, Connecticut, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of Massachusetts Worcester, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis

NCT04544449

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Alabama Neurology Associates Homewood, Alabama, United States
  • Sutter East Bay Medical Foundation Berkeley, California, United States
  • Fullerton Neurology and Headache Center Fullerton, California, United States
  • Palo Alto Medical Foundation Research Center Sunnyvale, California, United States
View all 190 locations
View Trial Details
Active, Not Recruiting

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

NCT04688788

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations
  • Danish Multiple Sclerosis Center, Rigshospitalet Glostrup Municipality, Copenhagen, Denmark
  • Department of Neurology, Aalborg University Hospital Aalborg, Denmark
  • Department of Neurology, Aarhus University Hospital Aarhus, Denmark
  • Department of Neurology, Hospital of South West Jutland, Esbjerg Esbjerg, Denmark
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

NCT05201638

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Neuro of Central Florida Altamonte Springs, Florida, United States
  • Healthcare Innovations Coral Springs, Florida, United States
  • Heratsi Hospital Complex 1 Yerevan, Armenia
  • Saint Gregory the Illuminator Medical Center Yerevan, Armenia
View all 76 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

NCT04035005

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • MS and Neuromuscular Center of Excellence Clearwater, Florida, United States
  • Neurological Services of Orlando Orlando, Florida, United States
  • Vero Neurology Vero Beach, Florida, United States
View all 155 locations
View Trial Details

Related conditions